Positron emission tomography molecular imaging-based cancer phenotyping

被引:21
|
作者
Jin, Chentao [1 ,2 ,3 ,4 ]
Luo, Xiaoyun [1 ,2 ,3 ,4 ]
Li, Xiaoyi [1 ,2 ,3 ,4 ]
Zhou, Rui [1 ,2 ,3 ,4 ]
Zhong, Yan [1 ,2 ,3 ,4 ]
Xu, Zhoujiao [1 ,2 ,3 ,4 ]
Cui, Chunyi [1 ,2 ,3 ,4 ]
Xing, Xiaoqing [1 ,2 ,3 ,4 ]
Zhang, Hong [1 ,2 ,3 ,4 ,5 ,6 ]
Tian, Mei [1 ,2 ,3 ,4 ]
机构
[1] Zhejiang Univ, Dept Nucl Med, Affiliated Hosp 2, Sch Med, Hangzhou, Peoples R China
[2] Zhejiang Univ, Positron Emiss Tomog Ctr, Affiliated Hosp 2, Sch Med, Hangzhou, Peoples R China
[3] Zhejiang Univ, Inst Nucl Med & Mol Imaging, Hangzhou, Peoples R China
[4] Key Lab Med Mol Imaging Zhejiang Prov, Hangzhou, Peoples R China
[5] Zhejiang Univ, Coll Biomed Engn & Instrument Sci, Hangzhou, Peoples R China
[6] Zhejiang Univ, Key Lab Biomed Engn, Minist Educ, Hangzhou, Peoples R China
基金
国家重点研发计划; 中国国家自然科学基金;
关键词
biomarker; cancer; cancer hallmarks; molecular imaging; positron emission tomography (PET); translational medicine; TUMOR-ASSOCIATED MACROPHAGES; PROSTATE-CANCER; BREAST-CANCER; AMINO-ACIDS; PET; EXPRESSION; VISUALIZATION; REPORTER; RECEPTOR; INFLAMMATION;
D O I
10.1002/cncr.34228
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
During the past several decades, numerous studies have provided insights into biological characteristics of cancer cells and identified various hallmarks of cancer acquired in the tumorigenic processes. However, it is still challenging to image these distinctive traits of cancer to facilitate the management of patients in clinical settings. The rapidly evolving field of positron emission tomography (PET) imaging has provided opportunities to investigate cancer's biological characteristics in vivo. This article reviews the current status of PET imaging on characterizing hallmarks of cancer and discusses the future directions of PET imaging strategies facilitating in vivo cancer phenotyping.
引用
收藏
页码:2704 / 2716
页数:13
相关论文
共 50 条
  • [41] Molecular imaging: The application of small animal positron emission tomography
    Rowland, DJ
    Lewis, JS
    Welch, MJ
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2002, : 110 - 115
  • [42] Molecular Imaging of Aortic Valve Stenosis with Positron Emission Tomography
    Oostveen, Reindert F.
    Kaiser, Yannick
    Stroes, Erik S. G.
    Verberne, Hein J.
    PHARMACEUTICALS, 2022, 15 (07)
  • [43] Positron emission tomography provides molecular imaging of biological processes
    Phelps, ME
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (16) : 9226 - 9233
  • [44] Positron emission tomography (PET) and molecular imaging for multiple sclerosis
    Stankoff, B.
    Freeman, L.
    Bodini, B.
    Bottin, L.
    Chardain, A.
    Lubetzki, C.
    Bottlaender, M.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 46 - 46
  • [45] Positron Emission Tomography and Molecular Imaging of Head and Neck Malignancies
    Farshad Moradi
    Current Radiology Reports, 8
  • [46] Imaging in laryngeal cancer: computed tomography, magnetic resonance imaging, positron emission tomography
    Zinreich, SJ
    OTOLARYNGOLOGIC CLINICS OF NORTH AMERICA, 2002, 35 (05) : 971 - +
  • [47] Positron emission tomography and single photon emission CT molecular imaging in schizophrenia
    Erritzoe, D
    Talbot, P
    Frankle, WG
    Abi-Dargham, A
    NEUROIMAGING CLINICS OF NORTH AMERICA, 2003, 13 (04) : 817 - +
  • [48] Clinical Positron Emission Tomography/Computed Tomography Quarter-Century Transformation of Prostate Cancer Molecular Imaging
    Chen, David C.
    Huang, Siyu
    Buteau, James P.
    Kashyap, Raghava
    Hofman, Michael S.
    PET CLINICS, 2024, 19 (02) : 261 - 279
  • [49] Imaging-based Laser Barcode for Cellular Phenotyping
    Jie, Randall Ang
    Qiao, Zhen
    Chen, Yu-Cheng
    2021 CONFERENCE ON LASERS AND ELECTRO-OPTICS (CLEO), 2021,
  • [50] Cancer imaging agents for positron emission tomography: Beyond FDG
    Paul, Asit K.
    Abdel-Nabi, Hani
    CURRENT MEDICAL IMAGING REVIEWS, 2007, 3 (03) : 178 - 185